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Abstract
As cancer related mortality decreases, the number of patients living with cancer
symptoms and the side effects of cancer treatment will continue to grow. In 2016, over 1.5
million Americans were newly diagnosed with cancer (American Cancer Society, 2016). Several
major medical organizations including the American Society of Clinical Oncology (ASCO), the
National Comprehensive Cancer Network (NCCN), and the World Health Organization (WHO)
endorse the integration of palliative care into cancer care (Ramchandran, 2015). Although many
cancer centers report offering palliative care, this remains largely limited to inpatient services.
The stakeholders of the hospice and palliative care division of a large Midwest healthcare
system have identified that there are many cancer patients who may benefit from palliative care,
but fail to receive these services. This is substantiated by a low number of oncology palliative
care referrals, a large portion of inpatient palliative care referrals occurring when patients are
critically ill, low median length of hospice enrollment among oncology patients, and a low rate
of oncology patients completing advance care planning prior to a hospice referral. The
development of an evidence-based toolkit to improve oncology referrals to palliative care could
improve timely and appropriate oncology referrals to palliative care. The Theory of Symptom
Management and the PARIHS framework were used to develop a toolkit to increase timely and
appropriate referrals to palliative care in this Midwest healthcare system. The toolkit includes a
cost savings analysis, referral recommendations based on analysis of current oncology quality
measure performance, marketing and educational materials for referring providers, an
implementation protocol, and a sustainability plan.
Keywords: “Oncology”, “palliative care”, “referrals”, “integration”, “collaboration”, “end
of life”
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Evidence Based Toolkit to Improve Oncology Referrals to Palliative Care
Executive Summary
Background
According to recent studies, although the majority of patients reported a preference to die
at home, 60% of deaths occurred in the hospital and the median hospice length of stay was a
mere 17.4 days (Gomes et al., 2013; National Hospice and Palliative Care Organization, 2015).
Furthermore, nearly a quarter of all Medicare spending incurred in beneficiaries’ last year of life
(Riley & Lubitz, 2010). Palliative care is one proposed solution to improving end of life care
(IOM, 2015).
Purpose
The physical and psychosocial symptom burden of cancer is high and can have
detrimental effects on patient and family quality of life (Greer et al., 2013). Consequently,
several major medical organizations including the American Society of Clinical Oncology
(ASCO), National Comprehensive Cancer Network (NCCN), and the World Health Organization
(WHO) endorse the integration of palliative care into standard cancer care (Ramchandran, 2015).
Unfortunately, although many organizations offer both oncology and palliative care services,
many are not fully integrated. The purpose of this DNP project is to propose a solution to the
current gap in care delivery.
Significance
Currently, despite widespread recommendations for the early integration of palliative
care into oncology care, patients are often referred to palliative care late in their disease course or
even worse, not at all (Rauenzhan et al., 2017; Reville et al., 2013; Schenker et al., 2014). This
represents a significant failure to provide evidence-based care to oncology patients as palliative
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care improves advance care planning (Kavalieratos et al., 2016), increases use of hospice (Kerr
et al., 2016; Lustbader et al., 2017), and lowers healthcare utilization (Lustbader et al., 2017).
Current Practice
The hospice and palliative care division of a large Midwest healthcare system has
identified a problem in patient access to palliative care services, specifically among oncology
patients. This is substantiated in data from the hospice and palliative care clinic collected from
December 2015 to September 2017, which demonstrated a low number of oncology palliative
care referrals (34.7% of total referrals), a large portion of inpatient palliative care referrals
occurring when patients are critically ill (18.9% in critical care and 12.9% in telemetry/step
down), low median length of hospice enrollment (mean 63 days, median 10 days), and only
31.2% of oncology patients completing advance care planning prior to a palliative care referral.
New Evidence
Evidence for the creation of the toolkit was systematically reviewed. First, barriers to
oncology referrals to palliative care were identified. Second, characteristics of successful
strategies to improve timely referrals to palliative care were evaluated. These analyses are
depicted in Appendix A. Finally; grey literature was reviewed for financial considerations. This
review identified a key area of opportunity in upcoming reimbursement changes (Appendix B).
Financial Considerations
Historically, oncology has been exempt from performance measures focused on hospital
readmission rates (Boccuti & Casillas, 2017). This will change with the implementation of The
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which will introduce
comprehensive Medicare reimbursement changes for healthcare services (CMS, 2017).
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These reimbursement changes usher in an era of new oncology performance indicators that are
quality, not volume focused. High priority measures for oncology include:
•

Proportion of patients who have completed an advance directive

•

Proportion of patients admitted to hospice for less than three days

•

Proportion of patients admitted to intensive care in the last 30 days of life

•

Proportion of patients who died from cancer without being admitted to hospice

•

Proportion of patients who received chemotherapy within 14 days of death

•

Proportion of patients who died from cancer with more than one emergency department
visit in the last 30 days of life (CMS, 2017).

Intervention
Considering this identified opportunity, given the current reimbursement climate, an
evidence-based toolkit was developed to improve oncology referrals to palliative care. The
toolkit includes:
•

Cost savings analysis based on current high priority oncology quality measure
performance

•

Referral guidelines

•

Marketing and educational tools for referring providers

•

Protocol for implementation of toolkit

•

Sustainability plan

Cost Analysis
Cost considerations for completion of the project include staff member time, DNP
student time (which is without cost to the organization) and costs of resources provided. The
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proposed project will result in a net gain of labor and resources for the organization. Appendix K
provides a detailed description of the project budget.
Recommendation
After the organizational assessment and literature review were complete, a
recommendation was made to create an evidence-based toolkit to improve timely and
appropriate referrals from oncology to palliative care. The toolkit was presented and accepted by
stakeholders within the hospice and palliative care division.
Results
Quality Measure Performance and Cost Savings Analysis. Current oncology quality
measure performance was assessed using a retrospective chart review. The results were used to
calculate current performance and resultant points under MACRA reimbursement criteria. A
potential Merit-based Incentive Payment System (MIPS) report card was produced. The lowest
performing quality measure was advance directive completion with 61.88% (N=160) of patients
assessed as not having an advance directive documented in their medical chart (Appendix N).
If current performance continues, the highest possible score if all points are awarded for
the remaining categories of improvement activities and advancing care information is 84.94%,
which will result in a 4% positive payment adjustment in 2019. However, if not all points are
awarded for the remaining two categories, the organization could receive no positive payment
adjustment or a negative payment adjustment if the total points awarded is less than 25 or no
data is reported. This analysis is depicted in Appendix O.
Referral Recommendations. The analysis did not determine the patient diagnosis, extent
of metastasis, or functional status to be independently associated with quality measure
performance. However, patients in the deceased group were more likely to have advanced
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disease and a lower functional status and for that reason, these populations in particular should
be considered for referral. Furthermore, this analysis supports that there were patients who
performed well in terms of functional status and metastasis and still performed poorly in quality
measure performance and vice versa. This supports current recommendations as set forth by the
National Academy of Medicine (IOM, 2015) that palliative care is offered to all patients with
serious illnesses. Final recommendations for referring providers are a combination of current
National Academy of Medicine recommendations and the results of the data analysis and are
summarized in Appendix Q.
Substantiated Value of Palliative Care. One result of this analysis was the
demonstrated benefit of palliative care on quality measure performance. For all analyses, a p
value of <.05 was considered significant. Among deceased patients (n=45), palliative care was
significantly associated with advance directive completion (60% vs 40%, p=.0189) and lower
intensive care unit (ICU) utilization (100% vs 0%, p=.0435). There were only 5 patients who
were admitted to the ICU in the 30 days preceding death and this small sample size does limit
this significance. Nonetheless, the results are promising and support that palliative care can
improve quality measure performance and ultimately reimbursement. This analysis is located in
Appendix R.
Marketing and Educational Tools. Index cards were produced to succinctly
communicate recommendations to referring providers. The de-identified version of the
marketing material is located in Appendix U. Palliative care clinicians also received printouts of
the data analysis with detailed explanations of results.
Implementation Protocol. A protocol for implementation of the toolkit was also
presented and accepted by hospice and palliative care stakeholders. The implementation
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protocol utilized the PARIHS framework for guidance. The theoretical outline of the
implementation plan is located in Appendix S. Appendix T contains stepwise instructions for
implementation. The stepwise instructions refer to feedback forms for both palliative care
clinicians and referring providers to evaluate the toolkit once it is implemented. These forms are
located in Appendix V and Appendix W respectively.
Sustainability. The hospice and palliative care division has a plan for program growth,
which includes hiring new physicians, nurse practitioners, and nursing staff as well as
innovative ways to deliver care such as through telehealth and expansion of home based care
services. In order for service lines to continue to develop, the division will need to continue to
increase in patient referrals. Both referral data and quality measure performance should be
monitored after implementation of the toolkit to measure success of the toolkit. Timelines for
evaluation are included in the implementation protocol. Evaluation tools are located in
Appendix X.
Conclusion
As cancer mortality decreases the number of individuals living with cancer will continue
to grow. Oncology patients stand to greatly benefit from the early integration of palliative care.
Unfortunately, the stakeholders of a hospice and palliative care division of a large Midwest
healthcare system have observed that oncology patients are being referred late in their disease
course to palliative care services, or even worse not at all. A quality improvement project
completed by a DNP student included the development of an evidence-based toolkit to improve
timely and appropriate referrals from oncology to palliative care.
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Introduction
Advances in healthcare have led to longer life expectancies for individuals with chronic
and life limiting illnesses. Consequently, the field of palliative care is growing to meet the
demands of this population (Kamal et al., 2016). Palliative care is the management of physical
and psychosocial symptoms due to a serious or life limiting illness. The goal of palliative care is
to improve patient and family quality of life (National Hospice and Palliative Care Organization,
2017). Over the past 15 years, the field of palliative care has grown exponentially. Over 1700
hospitals with more than 50 beds now offer a palliative care team and in more recent years
palliative care has expanded into the community (Center to Advance Palliative Care [CAPC],
n.d).
Although palliative care services are becoming more widespread, patient access to
palliative care remains limited. The shortcomings in end of life care were addressed in the 2015
National Academy of Medicine (formerly the Institute of Medicine [IOM]) report), Dying in
America. The report recommended expanding palliative care programs (IOM, 2015). According
to recent studies, although the majority of patients reported a preference to die at home, 60% of
deaths occurred in the hospital and the median hospice length of stay was a mere 17.4 days
(Gomes et al., 2013; National Hospice and Palliative Care Organization, 2015). The United
States is home to the most expensive healthcare system in the world with a price tag that will
account for 20% of the gross domestic product (GDP) by 2020 (Institute for Healthcare
Improvement, 2017). Much of this is spent on end of life care with nearly a quarter of all
Medicare spending incurred in beneficiaries’ last year of life (Riley & Lubitz, 2010).
Cancer patients may greatly benefit from palliative care. In 2016, over 1.5 million
Americans were newly diagnosed with cancer (American Cancer Society, 2016). The physical
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and psychosocial symptom burden of cancer is high and can have detrimental effects on patient
and family quality of life (Greer et al., 2013). Consequently, several major medical organizations
including the American Society of Clinical Oncology (ASCO), National Comprehensive Cancer
Network (NCCN), and the World Health Organization (WHO) endorse the integration of
palliative care into standard cancer care (Ramchandran, 2015). Although many cancer centers
report offering palliative care, this remains largely limited to inpatient services. Furthermore,
even fewer oncology clinics are fully integrated with palliative care (Hui et al, 2010).
Problem Statement
Currently, despite widespread recommendations for the early integration of palliative
care into oncology care, patients are often referred to palliative care late in their disease course or
even worse, not at all (Rauenzhan et al., 2017; Reville et al., 2013; Schenker et al., 2014). This
represents a significant failure to provide evidence-based care to oncology patients as palliative
care improves advance care planning (Kavalieratos et al., 2016), increased use of hospice (Kerr
et al., 2016; Lustbader., 2017), and lower healthcare utilization (Lustbader et al., 2017). In
addition, the national hospice median length of stay remains low at 17.4 days and 60% of
patients are dying in acute care settings although the majority preferred to die at home (Gomes et
al., 2013; National Hospice and Palliative Care Organization, 2015). Thus, the cost of care at the
end of life remains high while the quality of care provided is low.
The stakeholders of the hospice and palliative care division of a large non-profit Midwest
health care system have identified a similar problem with the quality of care provided to
oncology patients within the organization. Patient access to palliative care services, specifically
among oncology patients is limited. This is substantiated by a low proportion of new referrals
coming from oncology providers, a large portion of inpatient palliative care referrals occurring

TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE

12

when patients are critically ill, low median length of hospice enrollment among oncology
patients, and a low rate of oncology patients completing advance care planning prior to a hospice
referral. Considering this, what is an evidence-based toolkit to improve timely and appropriate
oncology referrals to palliative care that is feasible within this organization?
Evidence Based Initiative
Evidence for the creation of the toolkit was systematically reviewed. First, barriers to
oncology referrals to palliative care were identified. Second, characteristics of successful
strategies to improve timely referrals to palliative care were evaluated. A search was conducted
of the databases CINAHL and PubMed from September 20, 2017-September 27, 2017 for
articles published between 2007 and 2017. Key words for the search were “oncology”, “cancer”,
“palliative care”, and “referrals”. Studies selected for inclusion in the review were from peer
reviewed academic journals, adult patients, English language, and in the United States. Articles
that were not specifically about barriers or interventions to improve palliative care referrals to
oncology were eliminated. An initial search included 213 results after removal of duplicates, of
which 145 did not meet inclusion criteria, and 58 were excluded due to low statistical or
methodological rigor or were position papers or practice guidelines. The remaining 10 articles’
reference lists were reviewed resulting in an addition of 3 more articles. A total of 13 articles
were included in the review.
The studies included: one prospective cohort, one quasi experimental, multiple
retrospective chart reviews, and multiple qualitative studies including surveys, focus groups, and
structured interview. There could be several explanations for the level of evidence that is
available. First, palliative care patients are patients with severe and life limiting illnesses which
make them a population not amenable to rigorous randomized control trials that could jeopardize
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receiving the best level of care. Second, the disparity of oncology and a palliative care referrals
remains despite well-published research regarding the benefits of integrating palliative care into
oncology care and recommendations for the utilization of palliative care services from several
major medical organizations (Ramchandran, 2015). Thus, qualitative research regarding what the
referring providers perceive as their reasons for not referring is necessary to understand the
continued low referral rate. This disparity also represents a mismatch of evidence-based practice
and current practice that may explain the high volume of quality improvement interventions as
opposed to experimental research (American Academy of Family Physicians, n.d). Appendix A
displays both barriers and facilitators identified in the literature. Finally, financial considerations
for the integration of palliative care into oncology care were explored and are displayed in
Appendix B.
Barriers to Palliative Care Referrals
Access. Provider perceived burden on patients to spend more time at the clinic as well as
financial and disease concerns limiting ability to attend palliative care appointments were
commonly identified barriers in the literature (Rabow et al., 2016). Lack of oncology provider
awareness about locally available services was also identified as a potential barrier (Schenker et
al, 2014). Finally, long wait times for palliative care appointments were identified by oncologists
as a reason for not referring patients to palliative care (Feld, Horn, & Phillips, 2016). This
implies that having palliative care services physically close to an oncology clinic or even within
an oncology clinic alone is not a sufficient intervention to increase patient referral to palliative
care. Oncology provider awareness of available services is crucial as are timely appointments
and options to limit patient travel such as community based palliative care (CBPC) and
additional visiting clinic sites.
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Oncology Provider Knowledge. Results of several studies showed that oncology
providers’ knowledge about palliative care to be inadequate (Schenker et al., 2014; Walbert,
Glantz, & Pudvali, 2016; Feld, Horn, & Phillips, 2016). This included misconceptions about the
difference between hospice and palliative care, the inability to combine palliative care with
aggressive treatment, and the belief that palliative care could be adequately provided by
oncologists. This knowledge discrepancy also extended to nurses (Autor, Storey, & ZiembaDavis, 2013). Oncology providers also expressed hesitancy in discussing a palliative care referral
with patients and felt that the referral would not be well received by patients (Feld et al, 2016),
that a referral may alarm patients and their families (Smith et al., 2012), and even that patients
would equate a palliative care referral with death (Rabow et al., 2016). Thus, referring providers
need to be well equipped to discuss palliative care referrals with their patients and to be well
informed of the characteristics and features of palliative care.
Ease of Collaboration. Finally, the ease of which referrals are initiated as well as the
quality of ongoing collaboration between palliative care and oncology providers may impede
palliative care referrals. In a focus group of oncology clinicians, referrers felt that they needed to
feel confident in the quality and capability of the palliative care providers as well as to have
defined responsibilities and clear team communication (Le et al., 2014). In an analysis of
organizational factors influencing palliative care utilization at an academic cancer center, an
unwieldy referral process, lack of same day appointments, and inadequate communication
between palliative care and oncology providers were all identified as potential barriers (Le et al.,
2014). This supports the need for a referral process that is user friendly, fits in to office
workflow, establishes what services each specialty will provide, and sets clear expectations for
communication between oncology and palliative care providers.
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Effective Strategies to Improve Referrals to Palliative Care
Patient Screening and Defined Referral Criteria. Two studies implemented the
Edmonton Symptoms Assessment Scale (ESAS) to better identify patients who may benefit from
a palliative care referral. Hui et al. (2017) collected data pre, during, and post implementation of
the scale, which was administered by a medical assistant prior to appointments and reviewed by
a provider during the appointment. There was an increase in palliative care referrals from 12%
prior to the intervention to 28% after, however this was not deemed statistically significant.
Rauenzhan et al. (2017) implemented the ESAS in five oncology clinics after a brief staff
education session about the tool and the consultation ordering process. Referrals prior to the
intervention were an average of one patient per month and increased to an average of 10.8
patients per month.
Another study implemented eligibility criteria for automatic palliative care referrals to
expedite referrals to palliative care among patients with cancer identified in the literature to be at
high risk for uncontrolled symptoms, emotional distress, and prolonged hospitalization. Criteria
included advanced cancer (stage IV solid tumor or stage III lung or pancreatic cancer), prior
hospitalization within 30 days, hospitalization greater than 7 days, and active palliative
complaints. The result was a statistically significant increase in palliative care consultations
(39% to 80%) and hospice referrals (24% to 26%), as well as declines in 30- day readmission
rates (35% to 18%) and chemotherapy after discharge (44% to 18%) (Adelson et al., 2017). This
suggests that having established referral criteria may be a timely and easy to implement
intervention to increase referrals.
Provider Education. As identified above, lack of provider knowledge about palliative
care is a significant barrier to palliative care referrals. In a small but significant study of
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attending oncologists, one nurse practitioner, fellows, and house staff, a didactic presentation, an
education outreach visit, and pocket sized cards with referral criteria increased referrals from
24.9% to 31.5% in the 7.5 months post intervention. Interestingly, prior to the intervention the
majority of palliative care referrals were for end of life issues (44.1%), goals of care (37.3%),
and pain management (34.9%). After the intervention this was reversed with more referrals for
pain management (47.2%), goals of care (34.9%), and end of life issues (29.2%) (Reville,
Reifsnyder, MgGuire, Kaiser, & Santana, 2013). These results support that enhancing provider
knowledge about the services palliative care providers can provide as well as their competence to
provide these services and providing defined referral criteria may be a useful intervention in
increase oncology referrals to palliative care.
Branding. There are several studies that support that changing the name of palliative care
to “supportive care” may increase both referring provider and patient acceptance. In a survey of
17 oncologists at an academic cancer center, providers perceived that their patients were more
receptive to being offered supportive care rather than palliative care although they did not feel
that this would change their referral patterns (Rhondali, Burt, Wittenberg-Lyles, Bruera, & Dalal,
2013). Walbert et al. (2016) conducted an anonymous survey of 239 physicians, nurse
practitioners and physician assistants at an annual neuro-oncology meeting and found equivocal
results with 51% preferring the name supportive care rather than palliative care.
In a retrospective chart review of 4710 consecutive oncology patients seen for first time
palliative care consultations, consultations prior to a name change to supportive care were
compared to those after the name change. After changing the name of the service from palliative
to supportive care, 41% more palliative care consultations occurred, inpatient referrals increased
from 733 to 1451, outpatient referrals occurred sooner from hospital discharge, and median time
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from advance cancer diagnosis to palliative care consultation decreased 1.7 months (Dalal et al.,
2011).
Finally, in a randomized telephone survey of 169 patients with advance stage cancer,
patients were randomized into four groups that differed by name (supportive care versus
palliative care) and (patient-centered versus traditional). When compared to palliative care, the
term supportive care was associated with better understanding, more favorable impressions, and
higher future perceived need (Maciasz et al, 2013). Although there may be other environmental
and organizational changes occurring during these interventions that may have influenced these
results, this is promising evidence in support of including the term “supportive” care in the clinic
name or department description.
Financial Considerations
Several retrospective studies have demonstrated the relative cost savings of palliative
care from a health system perspective. This is largely due to increased use of hospice (Kerr et al.,
2014; Lustbader et al., 2017), fewer hospitalizations (Greer et al., 2016; Khandelwal et al., 2016;
Lustbader et al., 2017; Penrod et al., 2010) and lower direct costs accrued during hospitalizations
(McCarthy et al., 2015; Penrod et al., 2010; Starks et al.,2013; Whitford, Nilay, & Moriart,
2013). Cost savings could be used to bolster the argument in support of early integration of
palliative care. However, this may not be enough to motivate individual referring providers and
has been presented before by this organization to referring oncology providers to no avail.
Historically, oncology has been exempt from performance measures focused on hospital
readmission rates unlike other life-limiting illnesses such as heart failure and chronic obstructive
pulmonary disease (Boccuti & Casillas, 2017). This will change with the implementation of The
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which will introduce
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comprehensive Medicare reimbursement changes for healthcare services (CMS, 2017). These
reimbursement changes usher in an era of new oncology performance indicators that are more
quality, not volume focused. High priority measures for oncology include:
•

Proportion of patients with a completed Advance Directive

•

Proportion of patients admitted to hospice for less than three days

•

Proportion of patients admitted to intensive care in the last 30 days of life

•

Proportion of patients who died from cancer without being admitted to hospice

•

Proportion of patients who received chemotherapy within 14 days of death

•

Proportion of patients who died from cancer with more than one emergency department
visit in the last 30 days of life (CMS, 2017).

These changes may be powerful motivators for oncology providers as several of the high priority
oncology quality measures are directly related to palliative care (Howie & Peppercorn, 2013).
Summary of Evidence Based Initiative
The cause of the current disparity in oncology referrals to palliative care is multifactorial.
The solution will need to address numerous barriers in order to effectively improve oncology
referrals to palliative care. The most feasible strategy for this organization is the incorporation of
defined referral criteria. This was determined based on oncology provider preferences as well as
input from the stakeholders at the hospice and palliative care organization. This intervention was
also demonstrated to be effective in multiple studies in the literature review. The solution also
needs to demonstrate financial benefit to the organization as a whole. Thus, the clinical question
that was addressed is: what is an evidence-based toolkit to improve timely and appropriate
referrals from oncology to palliative care that is feasible within the identified Midwest healthcare
system?
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Conceptual Models
Conceptual models provide a lens through which to view and understand a phenomenon
of interest. This is done through a network of concepts and their relationships (McEwen & Wills,
2014). The development of an evidence-based toolkit to improve timely and appropriate
oncology referrals to palliative care is the phenomenon of interest. The conceptual model that
was used to better understand this population of patients and the symptoms that they experience
is the Theory of Symptom Management. Similarly, a framework for implementation can guide
the translation of evidence into practice. The Promoting Action on Research Implementation in
Health Services (PARIHS) provided the framework for the development of an evidence-based
toolkit to improve timely and appropriate oncology referrals to palliative care.
Theory of Symptom Management
The Theory of Symptom Management is a middle range nursing theory developed by
faculty at the University of California, San Francisco (UCSF) (UCSF School of Nursing
Symptom Management Faculty Group, 1994). The theory was originally developed to guide
nurses to manage distressing symptoms by eliminating the symptom or removing the distress of
the symptom (Humphreys et al., 2014). The theory has three major interactive concepts:
symptom experience, symptom management strategies, and symptom status outcomes (UCSF
School of Nursing Symptom Management Faculty Group, 1994).
Concepts. Theoretical concepts are defined as “the components of a phenomenon
necessary to understand the phenomenon” (McEwen, M., & Wills, E., 2014, pp.27). The
concepts of the Theory of Symptom Management are displayed in Appendix C and include
symptom experience, symptom strategies, and outcomes.
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Symptom experience. Symptom experience is how individuals perceive, evaluate, and
respond to what they are feeling (UCSF School of Nursing Symptom Management Faculty
Group, 1994). Putting this in the context of oncology patients who may benefit from palliative
care, cancer patients suffer from a wide array of physical and psychosocial symptoms of their
disease as well as side effects from their treatment (Greer et al., 2013). The goal of palliative care
is to understand the symptoms that patients experience and create plans of care that specifically
address these symptoms (National Hospice and Palliative Care Organization, 2017).
Symptom strategies. Next, symptom strategies are methods to minimize the symptom
experience (UCSF School of Nursing Symptom Management Faculty Group, 1994). When
applying this to oncology patients who may benefit from palliative care, palliative care providers
are trained to treat the symptoms of individuals living with chronic or life limiting illnesses and
are thus uniquely prepared to implement care plans to eliminate or minimize symptoms. These
strategies can include both pharmacological and non-pharmacological interventions and are often
a combination of both (National Institutes of Health [NIH], 2010).
Outcomes. Finally, outcomes refer to physical wellbeing, psychological wellbeing, and
quality of life (UCSF School of Nursing Symptom Management Faculty Group, 1994). Palliative
care comprehensively addresses all of these outcomes. Palliative care is associated with
improved patient quality of life, patient and caregiver satisfaction, and increased advance care
planning (Kavalieratos et al., 2016) as well as improved symptom burden (Shamieh et al., 2017).
Outcomes particular to this project are quality measure performance.
Domains. An updated version of the UCSF Theory of Symptom Management further
refined the three major concepts of the model by placing them within the context of three nursing
domains: person, health and illness, and environment (Dodd et al., 2001). Personal aspects refer
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to demographic factors such as age, gender, and race (Dodd et al., 2001). These factors were
collected to assess whether patient demographic variables affect palliative care referral or quality
measure performance. Environmental aspects refer to culture, beliefs, and the location
individuals live or access care (Dodd et al., 2001). The organization has identified that the
current visiting palliative care clinic at a metropolitan oncology office has left many patients
without access to palliative care services and that this is further exacerbated by a low rate of
oncology referrals to palliative care. Expanding palliative care services to include an additional
visiting clinic site or offering CBPC services to oncology patients could help address this gap in
care. However, an adequate referral base would need to be established. Finally, health and illness
refers to the current state of individuals’ health bearing in mind current diagnosis and disease
course (Humphreys et al., 2014). Palliative care clinicians treat patients holistically, all the while
assessing their current overall health status the current course of their cancer.
The concepts of the Theory of Symptom Management will be used to address barriers to
palliative care referral. Symptom strategies will be used to explain the conditions and symptoms
that palliative care clinicians treat including referral recommendations and to explain the services
included with palliative care to referring providers. Outcomes will be used to analyze the cost
savings of palliative care particularly as they are related to the new MACRA reimbursement
criteria. Finally, the domains provided further criteria to consider when creating the toolkit to
improve oncology referrals to palliative care. The personal domain was used to identify at risk
populations where current care discrepancies exist such as those outside the area of the current
visiting clinic and those demographic groups who receive fewer palliative care referrals. The
health and illness domain was used to explain the balance between the respective care of
palliative and oncology providers. This helps set boundaries and expectations and identifies
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barriers to effective oncology and palliative care collaboration. Finally, the environment domain
was used to describe the setting for implementation of the toolkit such as the main hospital
campus and regional sites.
The PARIHS Framework
The Promoting Action on Research Implementation in Health Services (PARIHS)
framework was designed to assist with the translation of evidence into practice (Kitson, Harvey,
& McCormack, 1998). Because incorporating palliative care into standard oncology care is the
best practice recommendation from numerous medical organizations, the PARIHS framework is
appropriate to use to develop an evidence-based toolkit to improve timely and appropriate
oncology referrals to palliative care (Ramchandran, 2015). The three major concepts of the
PARIHS framework are evidence, context and facilitation (Appendix D). The concepts are
directly related, so that the strongest environment for change occurs when evidence, context, and
facilitation are strong and the weakest environment for change occurs when evidence, context,
and facilitation are low (Kitson, Harvey, & McCormack, 1998). The concepts of the PARIHS
framework were applied to the hospice and palliative care division of a large Midwest healthcare
system in which the evidence-based toolkit was developed. The framework was also used to
develop an implementation protocol for the toolkit and will be discussed in the results section.
The relationships in the framework are displayed in Appendix D.
Evidence. Evidence includes research, practitioner expertise and experience,
community/intended population, and the local environment; all forms of evidence should be
assessed and evaluated for strengths and weaknesses. There is a wealth of research evidence in
support of the early integration of palliative care into standard oncology care. Palliative care is
associated with improved patient quality of life, advance care planning, patient and caregiver
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satisfaction, and lower healthcare utilization (Kavalieratos et al., 2016). Early palliative care may
lengthen survival time in certain patient populations, particularly cancer patients (Temel et al.,
2010). Finally, palliative care has also been demonstrated to decrease healthcare costs (McCarthy
et al., 2015; Penrod et al., 2010; Starks et al.,2013; Whitford, Nilay, & Moriart, 2013).
The organization stakeholders have identified that there are many cancer patients who
may benefit from palliative care, but fail to receive these services. Having cohesive and ardent
clinical views among staff is consistent with having strong practitioner expertise and experience.
Patient preference also generates evidence. Again, palliative care improves patient and caregiver
satisfaction (Kavalieratos et al., 2016).
Context. The context is the setting or environment in which a proposed intervention
takes place (Kitson, Harvey, & McCormack, 1998). This includes the culture and leadership
infrastructure of an organization. The Burke-Litwin (1992) model was used to conduct an
organizational assessment of the identified Midwest healthcare system and included an
assessment of culture and leadership.
The mission and values of the healthcare system influence the hospice and palliative care
division culture. The mission of the healthcare system is to improve the health of the
communities served and the system-wide vision is to be a national leader in healthcare. Both the
mission and vision of the healthcare system along with the support of the organization suggest
that creating an evidence-based toolkit to improve timely and appropriate oncology referrals to
palliative care is highly relevant and important to the organization.
The leadership within the organization is a vertical chain of command. The
measurements the organization uses are reported frequently and include national benchmarks
such as average length of stay on hospice and admissions to the hospice and palliative care
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programs. Of significance, is that the organization is not currently tracking the new Centers for
Medicare and Medicaid Services (CMS) high priority oncology measures. Baseline CMS
measures related to oncology were gathered as part of the project and assessed to assist with the
cost analysis proportion of the toolkit as well as to create sustainability of the movement to
improve oncology referrals to palliative care. These findings are discussed in the results section.
Facilitation. Facilitation includes the internal support provided by an organization to
promote and sustain change (Kitson, Harvey, McCormack, 1998). The organization is comprised
of individuals who are passionate about the work that they do and about ensuring that patients
have access to their services. The organization has repeatedly invested in quality improvement
and expansion as evidenced by the new CBPC program. The organization is also part of the
initial cohort of organizations implementing the Centers for Medicare and Medicaid Services
Medicare Care Choices Model (MCCM), which started in 2016 (Centers for Medicare and
Medicaid Services [CMS], 2017). Finally, the organization has hosted two prior Doctor of
Nursing Practice (DNP) students to implement change at the organization. Thus, the buy in and
the willingness to assist with change are high.
The PARIHS framework (Kitosn, Harvey, & McCormack, 1998) was used to assist with
the translation of evidence in to practice to create an evidence-based toolkit to improve timely
and appropriate oncology referrals to palliative care within an identified organization. The
evidence in the literature and clinician experience, context of the organization, and strong
facilitation within the organization were utilized to successfully create and disseminate the
toolkit to stakeholders within the organization.
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Need and Feasibility Assessment of the Organization
Assessment of Organizational Needs and Resources
The hospice and palliative care division of a large Midwest healthcare system has
identified a problem in patient access to palliative care services, specifically among oncology
patients. This is substantiated in data from the hospice and palliative care clinic collected from
December 2015 to September 2017, which demonstrated a low number of oncology palliative
care referrals (34.7% of total referrals), a large portion of inpatient palliative care referrals
occurring when patients are critically ill (18.9% in critical care and 12.9% in telemetry/step
down), low median length of hospice enrollment (mean 63 days, median 10 days), and only
31.2% of oncology patients completing advance care planning prior to a palliative care referral.
Implementing an evidence-based toolkit to improve oncology referrals to palliative care is one
way to help bridge this gap in the current care delivery.
An organizational assessment of the hospice and palliative care division and the
encompassing healthcare system was completed using the Burke Litwin Model of Organizational
Performance and Change (1992). The model provided a comprehensive assessment of the
organization through the evaluation of 12 variables, which explore organization structure and
feasibility. The variables are displayed in Appendix E (Burke & Litwin, 1992). As demonstrated
by the multidirectional arrows shown in the diagram, relationships between the variables may
occur through both positive and negative feedback and are interrelated. The variables located
towards the top of the diagram have a stronger influence on change than those located near the
bottom. The organizational assessment identified strong context and strong facilitation within the
organization.
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SWOT Analysis of Proposed Intervention
A SWOT analysis was conducted after the organizational assessment. A SWOT analysis
is a tool used to evaluate the strengths, weaknesses, opportunities, and threats to a project
(Zaccagnini & White, 2017). This helps to plan for and appropriate resources to weaknesses as
well as to maximize strengths and areas for growth. The SWOT analysis for development of an
evidence-based toolkit is displayed in Appendix F.
Strengths. The hospice and palliative care division stakeholders identified this problem
as well as expressed interest and support in finding a solution. This represents support to
complete the project. Secondly, the clinic is one of the largest palliative care programs in west
Michigan and under the umbrella of one of the largest healthcare systems in the Midwest, both
lending to financial and structural support. Finally, this organization has recently invested in
expanding community palliative care services and offering the Medicare Care Choices program.
This will provide some clinical infrastructure for growth that is already in place.
Weaknesses. The largest weakness was a reported history of reluctance among oncology
providers to refer patients to palliative and hospice services. The existing confusion within the
organization as well as the healthcare system about the differences between palliative care and
hospice and the programs currently offered also weakens the referral base. Confusion about what
palliative care entails was also identified as a barrier in the literature (Autor, Storey, & ZiembaDavis, 2013; Feld, Horn, &Phillips, 2016; Schenker et al. 2014).
Opportunities. Oncology has long been exempt from performance measures focused on
hospital readmission rates unlike other life-limiting illnesses such as heart failure and chronic
obstructive pulmonary disease (Boccuti & Casillas, 2017). The Medicare reimbursement changes
that will follow the implementation of MACRA usher in an era of new oncology performance
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indicators that are more quality, not volume focused. This represents an opportunity for the
hospice and palliative care division to tactfully market their services as providing services
targeted towards improving not only patient satisfaction but also, quality measures and
ultimately reimbursement (Howie & Peppercorn, 2013).
Threats. The largest threat to the proposed project was the cost analysis not
demonstrating significant value of palliative care services. There was also the potential for
inadequate planning for program growth. Because of this, an implementation and sustainability
plan were included in the toolkit.
Overall, the hospice and palliative care clinic stakeholders identified a gap in palliative
care delivery to oncology patients within their organization and were ready and willing to
participate in a solution to this problem. Strong evidence, context, and facilitating factors to
support this initiative were identified through an integrative literature review, organizational
assessment, and SWOT analysis.
Project Plan
Purpose of Project
The purpose of this DNP scholarly project was to develop a toolkit to improve timely and
appropriate oncology referrals to palliative care. This was accomplished by answering the
clinical question: What is an evidence-based toolkit to improve timely and appropriate oncology
referrals to palliative care that is feasible within this organization?
Objectives
An evidence-based toolkit to improve timely and appropriate oncology referrals to
palliative care completed the following objectives:
•

Collect baseline data to establish the current state of oncology measures
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Perform a cost savings analysis of current high priority oncology quality measure
performance utilizing MACRA reimbursement criteria to substantiate value by February
22, 2018

•

Establish referral recommendations for oncology providers utilizing a regression analysis
with the consultation of a Grand Valley State University graduate statistics student to
determine which patient demographics and disease characteristics are associated with
poor quality measures performance by February 22, 2018

•

Create protocol plan by February 23,2018 for implementation of toolkit which includes:
o Cost savings analysis based on current quality measure performance
o Referral recommendations for oncology clinicians
o Marketing and educational tools for referring clinicians
o Implementation protocol for palliative care clinicians
o Sustainability plan for palliative care clinicians

•

Create marketing and educational tools for referring oncology clinicians and present this
to organizational stakeholders on February 22, 2018

•

Create sustainability plan by February 22, 2018

•

Disseminate work to key stakeholders for acceptance for implementation on February
22, 2018.

Type of Project
The project was a quality improvement project. Quality improvement is defined as a
“systematic, formal approach to practice performance and efforts to improve performance”
(American Academy of Family Physicians [AAFP], n.d). Quality improvement involves analyzing
organizational culture, identifying and prioritizing practice problems, collecting and analyzing
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data, communicating results, and ongoing evaluation (AAFP, n.d). Organizational culture and the
practice problem were identified through the organizational assessment and SWOT analysis. The
data collected was current high priority oncology quality measures, which were analyzed for cost
savings potential utilizing MACRA reimbursement criteria and underwent a logistic analysis, ChiSquare, or Fisher’s exact test where appropriate to identify high-risk populations that should be
considered for early referral to palliative care. Finally, the results of the analysis were incorporated
into the toolkit that included an implementation and sustainability plan. The toolkit was
disseminated to key organizational stakeholders.
Setting and Needed Resources
The hospice and palliative care division of a large Midwest healthcare system was the
setting for this DNP scholarly project. The resources for this project included access to electronic
medical records to obtain patient data related to oncology quality measures as well as a laptop
with access to a secure hard drive and an organizational e-mail address. Staff time commitment
included time from quality improvement, administrative, and clinical staff to participate in
meetings and project discussions. A team was established at Grand Valley State University to
assist the DNP student in completing the project and included an organizational mentor
(Department Chief of the hospice and palliative care program), a committee member with an
expertise in in palliative medicine, a committee member that is a practicing palliative care
APRN, and a committee chair with an expertise in the DNP scholarly project. An informal team
was also established and included the manager of hospice and palliative care program
development and a graduate GVSU statistics student.
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Design for Evidence-Based Initiative
The PARIHS framework (Kitson, Harvey, & McCormack, 1998) was used to guide the
development of an evidence-based toolkit to improve timely and appropriate oncology referrals
to palliative care:
•

Evidence from a comprehensive literature review as well as clinician expertise guided
the development of the toolkit. Evidence from grey literature, which is literature that is
not published commercially and often includes reports, market research, and memoranda
was also used to further investigate CMS reimbursement and quality measures
(Grey.Lit.org, n.d).

•

Context also played a role. The current culture at the hospice and palliative care division
is strong and supportive of change and growth. The purpose of the toolkit is to address a
problem that clinicians have identified as a current gap in care.

•

Facilitation was also considered when developing an implementation and sustainability
plan. This included a cost analysis, referral guidelines, as well as an implementation and
sustainability plan including how and when to track quality measures and referral rates in
the future.

Participants
Participants for the project were the 418 patients whose charts were retrospectively
reviewed and the stakeholders and palliative care staff members who were presented the toolkit
for acceptance. The patient population are patients who were treated at one of the healthcare
system’s cancer centers from September 1, 2016- September 1, 2017. The stakeholders who
were presented the toolkit are the division chief, manager of program development, and at least
one clinician of the hospice and palliative care clinic.
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Measurement: Source of Data
Data collection to inform the toolkit was performed by the DNP student and
administrative staff. The data collected was used as a baseline and to perform a cost analysis of
what current reimbursement impact will be utilizing the new MACRA criteria. Data collected
was also used to perform an analysis to determine which patient demographics, cancer
diagnoses, and disease characteristics were associated with poor quality indicator performance
to guide referral recommendations. The cancer diagnoses that were analyzed were selected by
determining the cancers with the highest incidence in the U.S according to the National
Institutes of Health (NIH, 2014) in conjunction with cancer diagnoses that have been shown to
perform poorly for the quality measures being assessed. A literature review of cancers and
quality measure performance is located in appendix H.
Functional status was also frequently assessed in the literature as a potential independent
variable affecting quality measure performance. Due to the ease of use and demonstrated
validity in the literature, the Eastern Cooperative Oncology Group (ECOG) performance status
was used to assess functional status of the reviewed patients (Oken et al., 1982; Cleeland et al.,
2013). The ECOG tool is depicted in Appendix I. Whenever possible ECOG scores were taken
directly from clinician documentation. If a score was not explicitly stated, the DNP student
scored the patient based on their most recent office note physical assessment and self reported
symptom assessment sheet. The final list of collected variables is located in Appendix J.
The DNP student was required to complete and sign an Acknowledgement of Training in
Patient Privacy in Research training. The DNP student also completed electronic medical record
(EMR) training and was granted access to the EMRs used within the hospice and palliative care
division. These EMRs include EPIC and Cerner. Finally, the DNP student was granted access to
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the network where all of the documents for the hospice and palliative care division are stored
and shared. The data collected was for all patients treated at one of the healthcare system’s
cancer centers from September 1,2016-September1, 2017. Patients treated for a non-oncology
diagnosis were excluded. Sample size was calculated to be 160. A randomized selection was
used and pulled from the 418 charts reviewed meeting inclusion criteria. Charts were reviewed
to determine:
•

Age

•

Gender

•

Primary cancer diagnosis

•

Metastasis status

•

ECOG score (0-4)

•

Admission to palliative care services status

•

Advance Directive completion

•

Deceased status

•

Admission to hospice status

•

Hospice length of stay

•

Admission to intensive care in the last 30 days of life

•

Chemotherapy in the last 14 days of life

•

More than one emergency department visits in the last 30 days of life.

Appendix G contains the spreadsheet for data collection. A number was assigned to patients
to de-identify patient information. Data was stored on the organization’s network and
password protected.
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Budget. A budget was created to demonstrate time needed from hospice and palliative
cares team members to implement and sustain the toolkit as well as needed materials
(Appendix K).
Cost Savings Analysis. The toolkit includes an assessment of current quality indicators
and the reimbursement implications that will start in 2019 under MACRA. There is a 4%
penalty or reward depending on quality measure performance. In addition, this cost
adjustment will biannually increase until 2022 to a penalty or reward of 9% (CMS, 2017b).
Steps for Toolkit Development
The completion of this DNP scholarly project included (Appendix L):
•

Data collection retrospectively from patient charts utilizing EMRs to collect: Primary
cancer diagnosis, age, gender, metastasis, ECOG score, deceased status, admission to
hospice status, hospice length of stay, admission to palliative care services status,
admission to intensive care in the last 30 days of life, receipt of chemotherapy within the
last 14 days of life, and more than one visit to emergency department visit in the last 30
days of life

•

A cost savings analysis of current high priority oncology quality measure performance
utilizing MACRA reimbursement criteria to substantiate value

•

Referral recommendations for oncology providers utilizing a logistic analysis, ChiSquare, or Fisher’s exact test where appropriate with the consultation of a Grand Valley
State University graduate statistics student demonstrating any patient demographics,
disease characteristics, or functional status associated with worse quality measure
performance

•

Protocol plan for implementation of toolkit which includes:
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o Cost savings analysis based on current quality measure performance
o Referral recommendations for oncology clinicians
o Marketing and educational tools for referring clinicians
o Implementation protocol for palliative care clinicians
o Sustainability plan for palliative care clinicians
•

Presentation of the toolkit to key stakeholders for acceptance for implementation

•

Upload the toolkit to a digital folder within the protect hospice and palliative care
network drive

•

Defense of the final toolkit at Grand Valley State University

•

Upload the toolkit to ScholarWorks©.

Project Evaluation Plan
The evidence-based toolkit to improve timely and appropriate oncology referrals to
palliative care within a hospice and palliative care division of a large Midwest healthcare system
was evaluated based on acceptance by key stakeholders within the organization. Stakeholders,
which include the medical director, manager of business and program development, and an
organizational nurse practitioner, accepted the toolkit, which was the final outcome of this DNP
scholarly project.
Ethics and Human Rights Protection
The health system’s Institutional Review Board (IRB) determination was obtained and
concluded the project to be non-human research on 11/20/2017. Grand Valley State University
accepted the healthcare system’s determination and ruled equivocally on 11/26/2017. All data
was de-identified and kept on the health system’s internal drive and password protected.
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Business Model
This DNP scholarly project is the formation of a toolkit to increase appropriate referrals
to the organization. The time and work completed by the DNP student is without cost to the
organization. However, the organization invested time spent by administrative staff and
clinicians to attend meetings, project defense, and final defense as well as by providing a laptop
for the student from September 2017-April 2018. This budget is demonstrated in Appendix K.
Stakeholder Support
The key stakeholders within the hospice and palliative care division, which include the
medical director, manager of business and program development, and an organizational nurse
practitioner, identified a practice problem in oncology referrals to palliative care. They have
accepted a toolkit to address this problem. A letter indicating the organization’s support is
located in Appendix M.
Project Outcomes
Current Quality Measure Performance and Cost Savings Analysis
Current oncology quality measure performance was assessed using a retrospective chart
review. Of the 418 charts reviewed, 160 were included in the total population group using
randomization. There were 45 deceased patients and all deceased patients were used to assess
quality measures related to end of life. Advance directive completion is the only quality measure
that can be applied to the total population. The remaining five quality measures are all directly
related to end of life and only deceased patient data was utilized.
The results were used to calculate current performance and resultant points under
MACRA reimbursement criteria. A potential Merit-based Incentive Payment System (MIPS)
report card was produced. The lowest performing quality measure was advance directive
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completion with 61.88% of patients assessed as not having an advance directive. This was
followed by proportion not admitted to hospice and proportion admitted to hospice for less than
three days, both at 33.33%. Proportion of patients with greater than one emergency room visit
and proportion of patients admitted to ICU in the last 30 days of life followed at 11.11% each.
The best performing quality measure was proportion of patients who received chemotherapy in
the last 14 days of life with an occurrence rate of 8.89%. It is important to note that quality
measure performances are awarded points based on each score’s percentile to in relation to other
hospitals. Because these are new quality measures, these percentiles will not be established until
after the first performance year (2019). The target for these measures is estimated based on
similar quality measure percentiles, which have historically set stricter targets for measures
associated with higher costs such as hospitalizations and emergency room visits. This report
card is located in Appendix N.
If current performance continues, the highest possible score if all points are awarded for
the remaining categories of improvement activities and advancing care information is 84.94%,
which will result in a 4% positive payment adjustment in 2019. However, if not all points are
awarded for the remaining two categories, the organization could receive no positive payment
adjustment or a negative payment adjustment if the total points awarded is less than 25 or no
data is reported. The monetary analysis of these adjustments is based on average cost for one
emergency department visit as quoted by the organization’s insurance company and the average
cost of acute hospitalization per day in Michigan (Rappleye, 2015). It is imperative that
performance be improved while reimbursement adjustments are low, as 2019 cost adjustments
will be $40.00 for emergency room visits and $85.20 per ICU day but will increase to $90.00
per emergency room visit and $191.70 per ICU day in 2022. If this trend continues, the current
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performance of five ICU hospitalizations is currently a negative adjustment of $426.00 per day
with an average length of stay of three days, ultimately accruing a $1,278.00 negative payment
adjustment for 2019. In 2022, this same performance will result in a negative adjustment of
$958.50 per day total for the five patients, reaching $2,875.50 based on the current average
length of stay of three days. Similarly, the current emergency room visit performance of four
visits will result in a total of $160.00 negative adjustment in 2019 and will increase to $360.00
in 2022. This analysis is depicted in Appendix O.
Referral Recommendations
There were not enough observations among deceased patients run a logistic regression.
For categorical variables chi-square tests or Fisher’s exact test was used where appropriate. A
two- sample t-test was used to assess the relationship between patient age and quality measure
performance. All analyses considered a p value of less than .05 to be significant. There was no
significant relationship between gender or age for any of the quality measures aside from
females and hospice length of stay less than three days (p=0.022). There was no significant
relationship between metastasis, primary disease, or functional status and quality measure
performance. Thus, there is no easy way to predict which patients will ultimately perform poorly
in the assessed quality measures.
The deceased patients were more likely to have metastasis than the total population
(93.18% vs 41.25%) and more likely to have higher ECOG scores (51.11% ECOG 2 & 22.22%
ECOG 3, vs 56.88% ECOG 0 & 31.88% ECOG 1). This indicates that deceased patients were
more likely to have advanced disease and lower functional status. The ages between both groups
were equivocal with a mean age of 68.09 for the deceased group and a mean age of 67.43 for the
total group. Tables describing both groups are located in Appendix P.
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Based on this analysis, although metastasis and functional status were not independently
associated with poor quality measure performance, both variables were more common in the
deceased group and for that reason these populations should be considered for referral.
Furthermore, this analysis supports that there were patients who performed well in terms of
functional status and metastasis and still performed poorly in quality measure performance and
vice versa. This supports current recommendations as set forth by the National Academy of
Medicine (IOM, 2015) that palliative care is offered to all patients with serious illnesses. Final
recommendations for referring providers are a combination of current recommendations and this
analysis and are summarized in Appendix Q.
Substantiated Value of Palliative Care
One result of this analysis was the demonstrated benefit of palliative care on quality
measure performance. Among deceased patients, palliative care was significantly associated
with advance directive completion (60% vs 40%, p=.0189) and lower ICU utilization (100% vs
0%, p=.0435). There were only 5 patients who were admitted to the ICU in the 30 days
preceding death and this small sample size does limit this significance. Nonetheless, these
results are promising and support that palliative care can improve both quality measure
performance and ultimately reimbursement. This analysis is located in Appendix R.
Marketing and Educational Tools for Referring Providers
Index cards were produced to succinctly communicate recommendations to referring
providers. The de-identified version of the marketing materials is located in Appendix U.
Palliative care clinicians also received printouts of the data analysis with detailed explanations
of results.
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Implementation Protocol
A protocol for implementation of the toolkit, which includes: cost savings analysis,
referral recommendations, marketing and educational tools, implementation protocol, and
sustainability plan was presented and accepted by hospice and palliative care stakeholders. The
implementation protocol utilized the PARIHS framework for guidance. The theoretical outline
of the protocol is located in Appendix S. Appendix T contains stepwise instructions for
implementation. The stepwise instructions refer to feedback forms for both palliative care
clinicians and referring providers to evaluate the toolkit once it is implemented. These forms are
located in Appendix V and Appendix W respectively.
Sustainability
The hospice and palliative care division has a plan for program growth, which includes
hiring new physicians, nurse practitioners, and nursing staff as well as innovative ways to
deliver care such as through telehealth and expansion of home based care services. In order for
service lines to continue to develop, the division will need to continue to increase in patient
referrals. Oncology patients are a patient population that has been identified as not receiving
palliative services or receiving services late in their disease course. The clinicians within the
organization are dedicated to growing this population along with their program, thus supporting
the sustainability of a toolkit to drive an increase in oncology patient referrals.
Both referral data and quality measure performance should be monitored after
implementation of the toolkit to measure success of the toolkit. The next DNP student at the
organization will perform monitoring of new oncology referrals and quality measure
performance. Timelines for evaluation are included in the implementation protocol. The
organizational nurse practitioner that assisted in the completion of this project has agreed to
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continue her involvement in the implementation and sustainability of the toolkit. Evaluation
tools are located in Appendix X.
Implications for Practice
The stakeholders of the hospice and palliative care clinic have identified that there are
many cancer patients who may benefit from palliative care, but fail to receive these services.
The development of a toolkit to improve timely and appropriate oncology referrals to palliative
care will improve patient access to palliative care. As a direct result of this DNP project the
hospice and palliative care division is enacting a new “opt out” policy for oncology referrals to
palliative care to replace the current “opt in” policy. This means that all patients regardless of
primary cancer diagnosis, extent of metastasis, or functional status will receive a palliative care
referral. This will also improve patient and family satisfaction, increased use and length of stay
on hospice, and overall healthcare costs. Finally, as demonstrated by the data analysis,
increasing patient access to palliative care will improve oncology quality measure performance
and ultimately reimbursement for referring oncology providers.
Strengths
A major strength of the toolkit is that it was developed in cooperation with members of a
hospice and palliative care division that are supportive of using the toolkit and ensuring success
of the toolkit. The analysis performed demonstrated the value of palliative care in improving the
lowest performing quality measure, advance directive completion. This may be a substantial
motivator for referring providers. In addition, quality measure performance and the cost analysis
demonstrate opportunity for improvement to optimize reimbursement, which again may be used
as motivation for referring providers.
Weaknesses
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The major outcome of this project was the development of an evidence-based toolkit to
improve oncology referrals to palliative care. The major weakness of this project is that the
toolkit will still need to be implemented. Doctor of Nursing Practice projects may take on a
variety of forms and thus may not always include implementation of a practice change. Most
importantly, the DNP project needs to be driven by the clinical question or issue, which this
project was. This project is most accurately described as an exploratory DNP project as it
assessed the practices of healthcare professionals (oncology providers) and ultimately the
healthcare system to provide baseline data that will be used to drive practice improvement
(Moran, Burson, & Conrad, 2017).
Although the student has taken great care to include all possible necessities in the toolkit,
there is always the possibility that after implementation there may be the need to modify the
toolkit. This will be the responsibility of the next DNP student and the organizational nurse
practitioner that assisted in the completion of this project. Part of quality improvement work is
constant reevaluation.
Relation to Other Evidence/Healthcare Trends
Palliative care has been one of the fastest growing healthcare specialties in the United
States. Palliative care has been proven to increase patient satisfaction, improve symptom
management, decrease intensive care in end of life, and to lead to cost savings (Hughes &
Smith, 2014). Much of the demonstrated cost savings of palliative care in the literature has been
through avoidance of cost such as less intensive care. This project has demonstrated additional
cost savings in the form of improved quality measure performance to capture optimal
reimbursement for services.
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Barriers to the incorporation of palliative care into standard oncology care include
physician resistance and unrealistic patient and caregiver expectations (Hughes & Smith, 2014).
Through the development of the toolkit, the DNP student seeks to decrease physician resistance
among referring providers by demonstrating tangible benefit to palliative care services as well as
further define patients most likely to benefit. In a recently published proposed research agenda
for high value palliative care, the question of how to best change clinician behavior around a
palliative care referral was proposed (Courtright, Cassel, & Halpern, 2018). The implementation
of this toolkit is one novel approach to answer this question.
Limitations
This project had several limitations. First, the data analysis portion included a small
deceased patient population (n=45). This rendered one of the significant relationships, the
relationship of palliative care to ICU admission to be significant (p=.0435) but limited by a
small cell count. Of the 20 patients that received palliative care services, 16 received services as
inpatients and 4 received services as outpatients. Thus, there was not a large enough sample size
to determine if earlier palliative care involvement through outpatient services significantly
impacted outcome performance. There were two quality measures, admission to hospice and
length of stay on hospice that approached but did not reach significance (p=.0897 & p=.0823). A
potential future clinical question is: would significance have been reached with earlier palliative
care involvement, as this has been demonstrated in the literature. Although these are current
limitations, if referrals improve with implementation of the toolkit, there is a possibility that
these questions could be answered more precisely with a larger sample size. Therefore, part of
the sustainability plan includes monitoring quality measure performance. As the number of
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oncology patient referrals grows, this analysis could be replicated to reevaluate this and further
substantiate the value of palliative care on additional quality measure performance.
Reflections on Doctor of Nursing Practice Essentials
The American Association of Colleges of Nursing (ACCN) has established eight
essentials that define the curriculum of DNP programs. These essentials are the foundation upon
which a DNP prepared nurse is prepared to practice (AACN, 2006) In completing this scholarly
project the DNP student demonstrated all eight of the essentials.
Scientific Underpinnings for Practice
Scientific underpinnings for practice refers to the underlying body of knowledge that
governs nursing practice and includes an understanding of the health and illness continuum, the
interaction of patients and environment, the nursing interventions that affect these relationships,
and the theoretical foundations for practice (AACN, 2006). The DNP student assessed both
patient and disease characteristics and the intervention of palliative care to determine how these
independent variables affected oncology quality measures in order to inform referral guidelines.
In addition, the project was to develop a new practice approach and was grounded in the Theory
of Symptom Management.
Organizational and Systems Leadership for Quality Improvement and Systems Thinking
Organizational and systems leadership is demonstrated by the ability to develop and
evaluate care delivery with an emphasis on quality and efficiency of care provided (AACN,
2006). The student evaluated the delivery of palliative care at an organization and identified a
practice problem. Advanced communication and leadership skills were used to identify a
solution to the problem. Consideration was given to budgetary concerns, the diverse populations
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involved, and potential barriers to be faced upon implementation of the toolkit. This included an
implementation and sustainability plan.
Clinical Scholarship and Analytical Methods for Evidence-Based Practice
Scholarship and research form the foundations of doctoral education. This includes the
ability to critically assess evidence, apply relevant evidence to practice, design and implement
processes to evaluate practice outcomes, use information technology to collect and analyze
outcomes, and to disseminate findings from practice and research to the healthcare community
(AACN, 2006). The DNP student performed an integrative literature review to appraise
evidence relevant to the phenomenon of interest and used the findings of the review to design a
quality improvement project. The DNP student also completed a data analysis that was carried
out using the organizational EMR. Findings were disseminated through paper publication, poster
presentations, and an oral defense.
Information Systems/Technology and Patient Care Technology
The DNP prepared nurse should also have the ability to use information systems and
technology to transform healthcare. This includes the design, selection, and use of information
technologies to evaluate care outcomes and financial performance (AACN, 2006). The DNP
student utilized the organization’s EMR to conduct a retrospective chart review. The DNP
student also took great care to collect and store data securely.
Health Care Policy for Advocacy in Health Care
Competency in healthcare policy should include the appraisal of health policies,
leadership in the development of healthcare policies, and advocacy for the promotion of
healthcare policies as well as for justice and equity across all healthcare settings (AACN, 2006).
This project advocated for the availability of palliative care services to all oncology patients and
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directly resulted in a change to the current “opt in” referral policy to an “opt out” policy. In
addition, the DNP student participated in Nurse Practitioner advocacy day in Lansing, Michigan.
Interprofessional Collaboration for Health Outcomes
Competency in interprofessional collaboration refers to communication, collaborative,
and leadership skills to develop, implement, and sustain practice change (AACN, 2006). The
DNP student demonstrated interprofessional collaboration through working with palliative care
and oncology clinicians as well as administrative staff. Regular meetings were conducted as
well as frequent e-mail and phone communication between the DNP student and all participants
including physicians, management, nurses, and social work.
Clinical Prevention and Population Health
Clinical Prevention and population health refers to the ability to analyze epidemiological,
biostatistical, and environmental data as it pertains to individual and population health as well as
to evaluate care delivery models in relation to diverse populations (AACN, 2006). The DNP
student analyzed biostatistical data including primary cancer diagnosis, extent of disease,
functional status, and patient demographics. The DNP student incorporated the psychosocial
dimension of palliative care into this project through the application of the Theory of Symptom
Management.
Advanced Nursing Practice
Advanced nursing practice is demonstrated through the ability to perform a comprehensive
history and physical assessment, develop an appropriate plan of care, sustain relationships with
patients and their families, mentor other nurses, and education and guide individuals through
health transitions (AACN, 2006). During the completion of the DNP project, the student spent
time in both inpatient and outpatient palliative care settings seeing patients in conjunction with a
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nurse practitioner and palliative care physician. Additionally, assessing the clinical problem and
designing an effective solution was made possible by the clinical knowledge gained during the
completion of the advance practice nurse portion of the degree program. The DNP student has
also mentored two DNP students who will be at the same project site next year.
Dissemination of Outcomes
Dissemination of the evidence-based toolkit occurred through presentation to the
stakeholders of the hospice and palliative care organization. Project findings were also
presented at the Three Minute Thesis Competition at Grand Valley Statue University on
2/15/2018. The toolkit was presented at Grand Valley State University with the DNP student’s
project team in attendance as well as other graduate nursing students and faculty. A formal
paper detailing the scholarly project will be uploaded to ScholarWorks©. Finally, the DNP
student will present a poster detailing the project at the organization’s student poster rounds.
Conclusion
As cancer mortality decreases the number of individuals living with cancer will continue
to grow. Oncology patients stand to greatly benefit from the early integration of palliative care.
Unfortunately, the stakeholders of a hospice and palliative care division of a large Midwest
healthcare system have observed that oncology patients are being referred late in their disease
course to palliative care services, or even worse not at all. A quality improvement project
completed by a DNP student included the development of an evidence-based toolkit to improve
timely and appropriate referrals from oncology to palliative care.
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Appendix A
Barriers and Facilitators of Oncology Referrals to Palliative Care Identified in the Literature

Barriers
Inadequate referring provider knowledge
(Autor, Storey, Ziemba-Davis, 2013; Feld, Horn,

Facilitators
Name change to supportive care

&Phillips ,2016; Schenker et al ,2014).

(Dalal et al 2011; Macziasz et al.,2013; Rhondali,
Burt, Wittenberg-Lyles, Bruera, & Dalai, 2013;
Walbert et al.,2016).

Belief that referral would alarm patient
and/or families

Ease of referral (Le et al.2014)

(Smith et al. 2012; Feld, Horn, &Phillips, 2016; Le et al
(2014).

Defined communication and expectations (Le
et al,2014)

Long wait times for appointments, unsure of
locally available services
(Feld, Horn, &Phillips, 2016; Schenker et al , 2014)

Patient screening/ established referral criteria
(Rauenzhan et al.,2017; Hui et al., 2017; Adelson et
al., 2017)

Ease of collaboration (Le et al., 2014)
Provider education
(Reville, Reifsnyder, McGuire, Kaiser, & Sanana,
2013)
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Financial Aspects of Palliative Care: CMS 2017 Oncology Quality Measures
Measure Number

High Priority Oncology Measure

#453

Proportion receiving chemotherapy in the
last 14 days of life

#454

Proportion of patients who died from cancer
with more than one emergency department
visit in the last 30 days of life
Proportion admitted to the ICU in the last 30
days of life

#455

#456

Proportion not admitted to hospice

#457

Proportion admitted to hospice for less than
3 days

#047

Care Plan: Percentage of patients who have an
advance care plan of medical decision maker
documented in their medical chart
(CMS, 2017)
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Appendix C
Revised Theory of Symptom Management

Figure 1. Revised Symptom Management Conceptual Model. Reprinted from “ Advancing the
Science of Symptom Management”, by Dodd., M., Facione, N., Huphreys, J., Miaskowski, C., &
Rankin, S, 2001, Journal of Advanced Nursing, 33(5), 668-676.
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Appendix D
PARIHS Framework

Figure 2. A three dimensional matrix in which evidence, context, and facilitation can either
be expected to influence the outcome in a positive or negative way. Reprinted from
“Enabling the implementation of evidence based practice: A conceptual framework,” by EA.
Kitson, G. Harvey, & B. McCormack, 1998, Quality in Health Care, 7, 149-158. Copyright BMJ
Publishing Group Ltd.
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Appendix E
The Burke-Litwin Model of Organizational Performance and Change

Figure 3. A model of organizational performance and change. Reprinted from “A Causal Model
of Organizational Performance and Change.” By W.W Burke and G.H Litwin, 1992, Journal of
Management, 18(3), 528. Copyright 1992 by Southern Management Association

Appendix F
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SWOT Analysis of Project

Strengths
•

Staff member support

•

Size and strength of the organization
as a whole

•

CBPC clinic is already being piloted
for Heart Failure patients

Weaknesses
•

History of reluctance among oncology
providers to refer patients to palliative
care and hospice services.

•

Confusion within the organization as
well as the healthcare system about
the differences between palliative care
and hospice and the programs
currently offered

Opportunities
•

MACRA legislation fostering a move
towards performance indicators that
are more quality, not volume focused.

•

Building a collaborative relationship
with oncology providers

Threats
•

Multiple competing services in the
area that

•

The cost saving analysis not
substantiating value

•

Oncology providers not being
receptive

•

Too rapid of program growth leading
to inadequate staffing and resources

Appendix G
Spread Sheet for Data Collection
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Date Request Submitted: Initial Draft 10/18/17
Date by which this data is needed by requestor(s): Wednesday, December 13, 2017 (pending IRB)
Data Requestor(s): Katelyn Gettel, GVSU, Doctor of Nursing Practice (DNP) student
Intent: DNP project – Examining new CMS initiatives and changes to reimbursement with Oncology
quality measures. Data will be summarized in aggregate (there is no intent to share individual patient
data).
Timeframe of data being requested: A retrospective 12-month snapshot sometime in CY2017 (with the
ability to stratify by individual month as well)
Base Population Definition: All adult Oncology patients seen/ treated at the SH United Cancer Center
(outpatients) in Greenville, MI location with the ability to stratify by cancer diagnosis/primary site of
cancer.

Type of
Metric or
Measure

Metric or Measure
Title (column
headings within
the report)

Definition

Exclusion(s)

Operational
- Volume

Primary Cancer
Diagnosis/Primary
Site of Cancer

Pediatric
patients
(age 0-17)

Process

Total number of
patients who
received
chemotherapy in
the last 14 days
of life (if
deceased)
Total number of
patients who had
more than one
ED visit within the
last 30 days (prior
to death, if
deceased)
Total number of
patients who had
an ICU admission
at any time in the
3-month
timeframe being
queried
Total number of
patients who were
admitted to
Hospice and LOS
on Hospice.

Desire the ability
to sort by specific
primary cancer
diagnosis/primary
site of cancer
Total number of
patients who
received
chemotherapy in
the last 14 days
of life (if
deceased)
Total number of
patients who had
more than one
ED visit within
the last 30 days
(prior to death, if
deceased)
Total number of
patients who had
an ICU
admission at any
time in the 3month timeframe
being queried
Total number of
patients who
were admitted to
Hospice and LOS
on Hospice.

Process

Process

Operational
- Volume

Comparisons
(National
Best
Practice,
Benchmarks,
etc.)

Data Source
& Format

Additional
Comments and
Notes

ICD-10-CM
(diagnosis)
coded data

Pediatric
patients
(age 0-17)

CMS

Enterprise
Data
Warehouse
(EDW) for
retrospective
data -

Pediatric
patients
(age 0-17)

CMS

Enterprise
Data
Warehouse
(EDW) for
retrospective
data -

Pediatric
patients
(age 0-17)

CMS

Enterprise
Data
Warehouse
(EDW) for
retrospective
data -

Pediatric
patients
(age 0-17)

CMS

Enterprise
Data
Warehouse
(EDW) for

CPT procedure
code.

Would like ability
to stratify by
which Hospice,
Spectrum Health
Hospice or any

TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE

Type of
Metric or
Measure

Metric or Measure
Title (column
headings within
the report)

Definition

Exclusion(s)

Outcome or
Operational
– Volume

Total number of
patients who were
admitted to a
System Hospital

Total number of
patients who
were admitted to
a Delivery
System Hospital

Pediatric
patients
(age 0-17)

Outcome

Total number of
patients who have
expired.

Total number of
patients who
have expired.

Pediatric
patients
(age 0-17)

Comparisons
(National
Best
Practice,
Benchmarks,
etc.)

Additional Notes:

Appendix H
Literature Review of Proposed Variables

Data Source
& Format

retrospective
data Enterprise
Data
Warehouse
(EDW) for
retrospective
data Enterprise
Data
Warehouse
(EDW) for
retrospective
data – SH
LemmenHolton
Tumor
Registry, or
State of
Michigan
Decedent
Registry
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Additional
Comments and
Notes

other area
hospices
Would like ability
to stratify by
which SH
Hospital

Would like to
know how many
died in the
hospital and
from the State of
Michigan
Decedent
Registry, if
possible.
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Source

Design

Sample

Measurement/Data
Analysis

Findings

Limitations

CA dx

Quality
Measures

Blechman
et al.
(2013)

Retrospective
chart review

N=69
Pts with
metastatic
CA admitted
to ICU in
last 2 weeks
of life

EOL quality indicator
review

22 reported having an
advance directive (22%)
however, only 16 were found
on chart. 97% did not leave
the hospital. 50 (72%) died in
ICU, 17 (25%) of patients
died in hospital outside ICU,
and 2 (3%) were d/c home.

Small sample
size. No further
characterization
of patients
beyond
“metastatic
CA”.

Metastatic

AD, ICU
admission.

Earle et al.
(2004)

Retrospective
claims review

N= 28,777
Medicare pts
aged 65 and
older

Medicare Claims
review. Multivariate
analysis.

Among pts receiving
chemotherapy, 15.7% were
still receiving tx at EOL,
increasing from 13.8% in
1993 to 18.5% in 1996
(P<.001). Pts with 1> ED
visit increased from 7.2% to
9.2% (P<.001). ICU
admission w/in 30 days of
EOL increased from 8.1% to
9.4%,(P= .009).
Use of hospice increased
(28.3% to 38.8%, P<.001).
However, pts who rec’d
aggressive care who entered
hospice were more likely to
do so w/in 3 days of death
(35.6% v 12.1%, P<.001).
Greater availability of hospice
was associated with less
aggressive treatment. No
significant association
between cancer type/stage
and the aggressiveness of
care.
Most common CA dx
associated with ED visits:
Lung, bowel, breast, prostate,
& esophageal.

Only pts >65.
Did not include
all CA dx or
differentiate
disease stage.

Lung (53.152.8%)breast
( 33.1%)colorec
tal (34.134.8%),
GI.(9.89.1%).
From 19931996.

Chemotherapy
at EOL, ED
visits w/in 30
days EOL,
ICU
admission, use
of hospice,
LOS on
hospice

Green et al.
(2016)

Systematic
review

12 studies of
ED pts, 7
studies were
exclusively
CA pts.

Empiral studies

Henson et
al. (2016)

Mortality
Follow back
survey

N=681

Analysis of pooled data
from 2 mortality follow
back surveys

Mathew et
al. (2017)

Retrospective
cohort

N=274 pts
with
metastatic
breast CA tx
at university
CA Center
deceased
between
2010-2012

Chart review, Chi
Sqaure, Fisher’s exact
test, Wilcoxon ranks.
Multivariate logistic
regression

29.7% experienced 2 or more
ED visits, 17.1% spent > 30
days in the hospital, & 37.9%
died hospitalized. Pts w/
prostate or hematologic were
more likely to experience
aggressive care (adjusted OR
4.36, 95% CI 1.39-13.70 and
4.16, 95% CI 1.38-12.47).
Patients who had >5 GP
visits, community nursing, or
contact with CBPC were less
likely to experience
aggressive EOL care (AOR
0.27, 95% CI 0.15-0.49).
28 (10.2%) rec’d
chemotherapy w/in 2 wks
EOL& 62. (22.6%) rec’d
chemotherapy w/in 4 wks
EOL. No difference in
baseline characteristics of
disease (histology, HR status,
HER2 status, CNS disease).
However, younger age at
metastatic dx and increasing

Stage at
Presentation
Local (9.49.0%)
Regional
(22.8-23.2%)
Distant
(67.8-67.9%
)

Did not specify
what other CA
dx were studied
or stage of
disease. No
timeline from
ED visit to
EOL.
Inherent
limitations of
follow-back
design

Lung,
Bowel,
Breast,
Prostate,
Esophageal

ED visits

Prostate &
Hematologic
.

Aggressive
EOL care
Defined as: 2
or more ED
visits in last
30 days of
life, Greater
than or equal
to 30 days in
the hospital,
or death in the
hospital.

No account of
functional
status or QOL

Metastatic
Breast CA

Chemotherapy
within 2 or 4
weeks of
death.

TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE

65

number of organ systems
involved were predictors of
both 2 and 4 wk
chemotherapy use (age odds
ratio 0.94-0.99 & number of
organ systems 1.16-1.87).
Nappa et al
(2011)

Control trial

80 incurable
epithelial CA
pts, 160
control

80 incurable epithelial
cancer patients who
used the performance
Status in palliative
chemotherapy
questionnaire (PSPC)
before palliative
chemotherapy (PCT)
were compared to 160
controls across 4 cancer
centers in Sweden using
Chi square and nonparametric Whitney- U
test.

No significant difference
between PSPC and control in
terms of proportion receiving
PCT in last month of life.
Absolute proportion of
patients receiving PCT during
last month of life was 25%
(PSCP 23.8%, control 26.3%,
p=0.68).
Most common cancers were
colon 23 PSCP 25 control
(28.8%,28.1%), Breast 14
PSCP 27 control(17.5%,
16.9%), Upper GI 20 PSCP
41 control (25%, 25.6%).,
Urologic 9 USPC 17 control
(11.3%, 10.6%), Lung 3
PSCP 8 control (3.8%, 5%).
Performance status was
documented for 48% of
patients with no statistical
difference between groups.

Poor
documentation
of functional
status,
mismatch in
control vs
interventional
groups size.

Colon,
Breast,
Upper GI,
Urologic,
Lung,

Chemotherapy
within 30 days
EOL

Pacetti et
al. (2015)

Retrospective
chart review

Descriptive statistic
analysis

Metastatic
Lung, GI,
Pancreatic,
ORL

Chemotherapy
within 30 days
EOL.

Retrospective
cohort

162 (24.3%) received
chemotherapy within 30 days
EOL. Median ECOG status
2. All with metastatic dx.
Lung CA 49(30.3%), G.I
31(19/2%), Pancreatic 25
(15.4%), ORL 14( (8.6%).
Overall 14.7% > 1 ED visit
in 30 days EOL, 15.4% had
ICU admission w/in 30 days
EOL, 12.2% expired in ICU,
10.4% received
chemotherapy w/in 14 days
EOL , 59.9% admitted to
hospice, 13.6% admitted to
hospice for <3 days for a
median stay of 14 days.
Hematologic malignancies
were associated w/ ICU
admission, chemotherapy
w/in 14 days EOL, more
likely to die in the ICU, &
less likely to be enrolled in
hospice (P<.001).
Gynecologic CA were more
likely to experience >1 ED
visit w/in 30 days EOL
(P<.04).

Excluded
hematologic
malignancies,
small sample
size

Stuver et al
(2016)

N=2164 with
advanced
CA who
rec’d
chemotherap
y from 20102012
N= 674
Pts who died
from 7/201012/2012
insured by
BCBS of
MA

Potential
inaccuracy of
claims data

Breast, GI,
GU,
Gynecologic,
head/neck
Hematologic
, Thoracic

ED visit 30
days EOL,
ICU
admission 30
days EOL,
Chemotherapy
14 days EOL,
Hospice
admission,
Hospice LOS,
Death in ICU

Claim data.
Chi square

Appendix I
Eastern Cooperative Oncology Cooperative (ECOG) Tool
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Toxicity and response criteria of the Eastern Cooperative Oncology Group. Reprinted from
“ Toxicity and Response Criteria of the Eastern Cooperative Oncology Group”. By Oken,
M.M., Creech, R.j., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., & Carbone, P.P, 1982,
American Journal of Clinical Oncology, 5, 649-655. Copyright The Eastern Cooperative
Oncology Group, Robert Comis, M.D., Group Chair

Appendix J
Variables Analyzed
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Measurement

1. > 1 Emergency Room visits within 30 days of death

Y/N

2. ICU admission within 30 days of death

Y/N

3. Advance Directive Completion Status

Y/N

4. Expire without admission to hospice

Y/N

5. Hospice LOS <3 days

Y/N

6. Chemotherapy within 14 days of death

Y/N

Independent Variables
Breast
Lung/Bronchus
Prostate
Colon/Rectum/Esophageal
Renal/Bladder
Hematologic
Gynecologic
Pancreas
Gender
Age
Metastasis (defined as spread beyond initial organ system and local lymph nodes)
Receipt of Palliative care services (as inpatient or outpatient)
ECOG score (0-4)
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Appendix K
Budget for Project

Table 1 Budget for Project
Personnel or Item
Chief of Department

Hourly Wage X Projected
Time
1,200

Manager of Program
Development
APRN

400

DNP Student

8,400

Cost of Item

450

Laptop

1200

Total

6350

Net

5,150

1200
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Appendix L
Timeline for Steps of Program Development

Chart review/
data collection
1/26/18

Referral criteria
based on regression analysis
2/23/18

Cost savings analysis
2/23/18

Marketing/educational Present toolkit to Upload to
for referring providers stakeholders
3/6/18
2/23/18
3/9/2018
Scholarworks©

Protocol for implementing
toolkit 2/23/18

Sustainability plan
2/23/18

Defend final toolkit
3/9/18
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Appendix M
Organization Letter of Support
To whom it may concern,
This letter is to verify that GVSU DNP student, Katelyn Gettel is completing her
scholarly project entitled “Toolkit to Improve Oncology Referrals to Palliative Care”
at Spectrum Health Hospice and Palliative Care. She will be working with Dr. Simin
Beg as her organizational mentor. The project will be complete in April of 2018.
We appreciate the opportunity to host a DNP student and will provide Kate with the
information and resources that she needs to complete her project.
Sincerely,

Angela Kinch, RN, BSN
Manager of Business and Program Development
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Appendix N
Quality Measure Performance

Table 2 MIPS Scorecard
Category

Weight

Possible
Points

Estimated
Points

Possible
Score

Quality
Improvement
Activities
Advancing Care
Information
TOTAL

60%
15%

60
40

44.94
40

60
15

Estimated
Weighted
Score
44.94
15

25%

100

100

25

25

100%

200

184.94

100

84.94

Table 3 Current Performance with Assigned Points
Sample
Size
45

Measure
Number
453

45

454

45

455

45

456

45

457

160

047

High Priority Oncology
Measure
Proportion of patients
who received chemotherapy in
last 14 days of life
Proportion of patients who died
from CA with >1 ED visit within
last 30 days of life.
Proportion of patients admitted to
ICU in last 30 days of life
Proportion not admitted to hospice

Current
Status
8.89%

Proportion admitted to hospice for
less than 3 days
Proportion without Advance
Directive in chart

33.33%

Target
*Estimated
<*20%

Estimated
Points
10

11.11%

*Estimated
<10%

8.89

11.11%

*Estimated
<10%
*Estimated
<20%
*Estimated
<20%
*Estimated
<20%

8.89

33.33%

61.88%

*percentiles for these quality measures are not yet established

6.67
6.67
3.82
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Appendix O
Cost Saving Analysis
Table 4 Payment Adjustment Key
Final Score

Payment Adjustment

Additional performance
threshold >70 points

•
•

4-69 points

•
•

Performance
threshold= 3 points
O Points

•

Positive Adjustment
Eligible for additional adjustment for
exceptional performance bonus
Positive Adjustment
Not eligible for additional adjustment
for exceptional performance bonus
Neutral Adjustment

•
•

Negative payment adjustment of -4%
0 points- does not participate

Estimated
Payment
Adjustment
100
75

25
0

Table 5 Estimated Cost Adjustments Based on Performance
Cost of Service

Adjustment
2019
+/- 4%

Adjustment
2022
+/- 9%

$40.00

Adjustment X
Current
performance
2019 (5 patients)
$200.00

$90.00

Adjustment X
current
Performance
2022 (5 patients)
$450.00

ED visit
$1,000
ICU Admission
$2,130/day

$85.20

$426.00

$191.70

$958.50
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Appendix P
Description of Total and Deceased Population

Table 6a Total Population Age (N=160)
N
Age

160

Mean Standard
Deviation
67.43 11.36

Table 6b Deceased Population Age (n=45)
N
Age

45

Mean Standard
Deviation
68.09 13.08

Table 7a Gender of Total Population (N=160) Table 7b Gender of Deceased Population (n=45)
Gender
Male
Female

Frequency Percent
59
36.88%
101
63.13%

Gender Frequency Percent
Male
25
55.56%
Female 20
44.44%

Table 8a Primary Cancer Total Population (N=160) Table 8b Primary Cancer Deceased (n=45)
Primary
Bladder
Breast
Cholangiocarcinoma
Colon
Esophageal
Gynecologic
Hematologic
Liver
Lung
Pancreatic
Prostate
Rectal
Renal

Frequency
3
52
1
19
4
6
22
3
33
3
6
4
4

Percent
1.88%
32.50%
0.63%
11.88%
2.50%
3.75%
13.75%
1.88%
20.63%
1.88%
3.75%
2.50%
2.50%

Table 9a Metastasis Total Population (N=160)
Metastatic
No

Frequency Percent
94
58.75%

Yes

66

41.25%

Primary
Bladder
Breast
Cholangiocarcinoma
Colon
Esophageal
Gynecologic
Hematologic
Liver
Lung
Pancreatic
Prostate

Frequency
2
3
1
7
4
2
3
1
15
4
3

Percent
4.44%
6.67%
2.22%
15.56%
8.89%
4.44%
6.67%
2.22%
33.33%
8.89%
6.67%

Table 9b Metastasis Deceased (n=45)
Metastatic
Frequency Percent
No
9
6.82%
Yes
41
93.18%
Frequency Missing = 1
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Appendix P
Description of Total and Deceased Population
Table 10a ECOG Total Population (N=160)
ECOG
0
1
2
3

Frequency
91
51
11
7

Percent
56.88%
31.88%
6.88%
4.38%

Table 11a Palliative Care Total (N=160)
PC
No
Yes

Frequency Percent
150
93.75%
10
6.25%

Table 10b ECOG Deceased (n=45)
ECOG
1
2
3
4

Frequency
6
23
10
6

Percent
13.33%
51.11%
22.22%
13.33%

Table 11b Palliative Care Deceased (n=45)
PC Frequency Percent
No 25
55.56%
Yes 20
44.44%
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Appendix Q
Recommendations for Referring Oncology Providers
All patients with a life limiting illness should be considered for referral to palliative care
services. Particularly those patients who:
•

Have advanced disease (metastasis) or locally aggressive disease

•

Have failed first line therapy

•

Have a low functional status ECOG ≥ 2

•

Have a need for goals of care discussion or advance care planning

•

Have had multiple ED or inpatient admissions for uncontrolled symptoms
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Appendix R
Predictors of Quality Measure Performance
Table 12 Deceased Patients Predictors of Outcome Performance (n=45)
Independent

Dependent

P-value

Test

Significant

Gender

AD
ED
ICU
Hospice
Hospice LOS < 3 days
Chemo w/in 14 days of death
AD
ED
ICU
Hospice
Hospice LOS < 3 days
Chemo w/in 14 days of death
AD
ED
ICU
Hospice

0.9465
0.3577
0.2799
0.6714
0.0222
0.1913
0.3443
0.7460
0.6900
0.2299
0.2209
0.7460
0.0189
0.3577
0.0435
0.0897

Chi-Square
Fisher’s
Fisher’s
Chi-Square
Fisher’s
Fisher’s
Fisher’s
Fisher’s
Fisher’s
Fisher’s
Fisher’s
Fisher’s
Chi-Square
Fisher’s
Fisher’s
Chi-Square

No
No
No
No
Yes
No
No
No
No
No
No
No
Yes
No
Yes
No

Hospice LOS < 3 days
Chemo w/in 14 days of
death

0.0823
0.3087

Fisher’s
Fisher’s

No
No

Metastatic

PC

Table 13 Two Sample t-test Deceased Patients Age as Predictor of Outcome Performance(n=45)
Independent Dependent
Age

Pvalue
0.7906

AD

Significant?
No

Table 14 Logistic Regression Predictors of Advance Directive in Total Population (N=160)
Predictor
Gender
Primary
Metastatic
ECOG

P-value
0.6144
0.9873
0.7008
0.5690

Significant?
No
No
No
No

Table 15 Two Sample t-test Predictor of Advance Directive using Age Total Population (N=160)
Predictor
Age

P-value
0.0033
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Appendix S
Implementation of Toolkit Utilizing PARIHS Framework
Table 16
Concept
Evidence
Research

Action

Literature review summarizing benefits of incorporating palliative care
into oncology care, facilitators and barriers to integration of palliative
care in to standard oncology care, and grey literature regarding
upcoming reimbursement changes.
Clinical
Organizational Assessment included review of referral statistics and
experience interviewing administrative and clinical palliative care staff members
and demonstrated low number of oncology referrals to palliative care.
Local
A retrospective chart review was completed revealing data about current
information oncology quality measures in need of improvement.
Context
Culture
Define current values: Providing the best care possible to patients with
life limiting illnesses. Resources allocated to growth and development
was established in organizational assessment (Currently hiring
physicians and RNs, new care choices and CBPC program).
Leadership Vertical chain of command is well established. Both medical director,
manager of practice development, and administrative VP are devoted to
organizational values as established in organizational assessment.

Evaluation

Roles

Skills/
Attributes

10/2017

9/2017

1/2018

9/2017

9/2017

Current DNP student will service as “champion” for the toolkit followed
by another DNP student. Strong support for DNP students within the
5/2018
organization.
Success of current project will be measured by acceptance of toolkit.
2/2018
Implementation of toolkit success will be measured by comparing pre
and post oncology referral statistics and quality measure performance

Facilitation
Purpose

Time

The purpose of this toolkit is to promote incorporating evidence based
standards into practice (incorporation of PC into standard oncology
care). It will be important that this is emphasized in presentation to
stakeholders and in communicating with referring providers.
APPs and physicians need to provide evidence based palliative care that
promotes patient autonomy and ultimately high quality measure
performance. This will need to be established during presentation to
stakeholders and reinforced periodically.
Palliative care staff members should also be encouraged to foster
professional relationships with referring oncology providers, as ease of
collaboration was an identified barrier in the literature.
Marketing Skills: Marketing tools will be produced and distributed.
Giving Meaning: Reinforcing the value in both cost savings and quality
performance. Disseminating results of implementation.

1/2019
2/2018ongoing

2/2018ongoing

2/2018
2/2018ongoing
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Appendix T
Steps for Implementation of Toolkit
1. Present toolkit to organizational stakeholders on 2/16/2018
2. Present toolkit to palliative care clinicians on 2/22/2018
3. Await permission from hospice and palliative care manger of practice and development to
disseminate marketing/educational materials to referring providers. Note, this will likely be after
the new EMR regional go- live (April-May of 2018) and after the posted FTEs for new
physicians and nurses have been filled
4. Disseminate marketing and educational tools to referring providers at downtown campus
estimated 9/2018
5. Change champion (either volunteer clinician or next DNP student) participate in rounds at
hospital with palliative care team to monitor for any questions or feedback using palliative care
staff feed back form
6. Collect post implementation data 12/2018 utilizing referral tracking table and quality measure
performance tracking table
7. Evaluate post implementation data. If there is improvement in number of oncology referrals
proceed to step 8. If no improvement in referrals, proceed with evaluation of referring providers’
response to the materials using referring provider feedback form, modify as necessary and return
to step 4
8. Disseminate marketing and educational tools to referring providers at regional campuses with
access to palliative care services
9. Repeat steps 5-7.
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Appendix U
Marketing and Educational Material

Comprehensive Medicare and Medicaid Reimbursement Changes coming in 2019 focus on quality measure
performance. There are 6 new high priority oncology diagnoses related to end of life care.
•

Proportion of patients with a completed Advance Directive

•

Proportion of patients admitted to hospice for less than three days

•

Proportion of patients admitted to intensive care in the last 30 days of life

•

Proportion of patients who died from cancer without being admitted to hospice

•

Proportion of patients who received chemotherapy within 14 days of death

•

Proportion of patients who died from cancer with more than one emergency department visit in the last
30 days of life (CMS, 2017).

Considering palliative and supportive care?

In an analysis of 45 deceased patients treated at ******** patient age, primary cancer diagnosis,
extent of disease, and functional status were not associated with quality measure performance.
Palliative and Supportive Care
Was significantly associated with advance directive completion (60% vs 40%, p=.0189)
Was significantly associated with lower ICU utilization in last 30 days of life (0% vs 100%,
p=.0435)*
* limited by small sample size

TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE

80

Appendix V
Palliative Care Staff Member Feedback Form
1. The marketing and educational materials have led to increased awareness about palliative care
referrals among oncology providers.
Strongly disagree

Disagree

Neutral

Agree

Strongly agree

2. I feel comfortable giving the materials to referring providers who have not already received
them.
Strongly disagree

Disagree

Neutral

Agree

Strongly agree

3. I feel comfortable discussing or answering questions about the materials with referring
providers.
Strongly disagree

Disagree

Neutral

Agree

Strongly agree
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Appendix W
Referring Provider Feedback Form
1. The marketing and educational materials have increased my awareness about what value
palliative care can bring to my practice
Strongly disagree

Disagree

Neutral

Agree

Strongly agree

2. The marketing and educational tools have improved my ability to talk with my patients about
a palliative care referral.
Strongly disagree Disagree

Neutral

Agree

Strongly agree

3. I believe that incorporating palliative care may improve my end of life quality measure
performance
Strongly disagree

Disagree

Neutral

Agree

Strongly agree

4. The materials have led me to change my referral practices
Strongly disagree

Disagree

Neutral

Agree

Strongly agree
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Appendix X
Evaluation Tools for After Toolkit Implementation
Table 17 Referral Data Tracking Sheet
MRN

Age

Gender

Diagnosis

Care Level

LOS at time
of Consult

Table 18 Quality Measure Performance Tracking Sheet
MRN

Primary
CA

PC

AD

Deceased?

ED within 30
days of death

ICU w/in
30 days
of death

Hospice

Hospice
LOS <3
days

Chemo w/in
14 days of
death

